Literature DB >> 7589112

Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony-stimulating factor/interleukin-4.

H Thomssen1, M Kahan, M Londei.   

Abstract

Interleukin (IL)-10 down-regulates HLA class II molecules, whether constitutively expressed or up-regulated by interferon-gamma or IL-4 on monocytes but not on B lymphocytes. In this study we show that IL-10 does not inhibit HLA class II expression induced by the combination granulocyte/macrophage colony-stimulating factor and IL-4 on monocytes, although it simultaneously abrogates the expression of CD1 molecules induced by the same combination of cytokines. CD1 molecules can act as element of genetic restriction for CD4- CD8- T lymphocytes, and the suppression of CD1 expression by IL-10 abolished antigen presentation to CD1-restricted CD4- CD8- T cell receptor-positive T cells. Although HLA class II expression was not down-regulated by IL-10, the antigen specific proliferative response of CD4+ T cells was nevertheless decreased. This was not caused by down-regulation of known co-stimulatory molecules such as B7.1, B7.2 and ICAM-1. IL-10 decreased the antigen specific proliferative response further by directly influencing the T lymphocytes. Our results indicate that IL-10 exerts some of its immunoregulatory functions by differential modulation of antigen presenting molecules, induced by the same combination of cytokines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589112     DOI: 10.1002/eji.1830250909

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells.

Authors:  P Méndez-Samperio; E Garcia-Martinez; M Hernandez-Garay; M Solis-Cardona
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 2.  CD1 presentation of microbial nonpeptide antigens to T cells.

Authors:  D Jullien; S Stenger; W A Ernst; R L Modlin
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Regulation of major histocompatibility complex class II synthesis by interleukin-10.

Authors:  Anne-Sophie Morel; Gary Coulton; Marco Londei
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

5.  Antigen-specific regulation of CD1 expression in humans.

Authors:  M Ulanova; A Tarkowski; S A Porcelli; L A Hanson
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

6.  Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells.

Authors:  A Giuliani; S P Prete; G Graziani; A Aquino; A Balduzzi; M Sugita; M B Brenner; E Iona; L Fattorini; G Orefici; S A Porcelli; E Bonmassar
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.

Authors:  Gianni Gerlini; Adrian Tun-Kyi; Christa Dudli; Günter Burg; Nicola Pimpinelli; Frank O Nestle
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients.

Authors:  Vineeta Chattree; Neena Khanna; Vandana Bisht; D N Rao
Journal:  Mol Cell Biochem       Date:  2007-11-16       Impact factor: 3.396

9.  The Immunostimulatory Capacity of Nontypeable Haemophilus influenzae Lipooligosaccharide.

Authors:  Gabrielle N Gaultier; Kayla N Colledanchise; Alaa Alhazmi; Marina Ulanova
Journal:  Pathog Immun       Date:  2017-02-16

Review 10.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.